A61K47/30 - CPC Classification Index

ClassID:

21273 ⎘

A61K47/30 - CPC Classification

Classification description:

Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates

Sub-classes:

A61K47/32 » Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, {e.g. carbomers, poly(meth)acrylates, polyvinyl pyrrolidone} 4,6K
A61K47/34 » Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, {e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer } 5,4K
A61K47/36 » Polysaccharides; Derivatives thereof, {e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin} 4,8K
A61K47/42 » Proteins; Polypeptides; Degradation products thereof; Derivatives thereof {e.g. albumin, gelatin, zein } 2,6K

Recent Application in this class:

20260130855

2026-05-14

GAMMA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

20250387415

2025-12-25

COMPOSITIONS OF COPPER COMPLEXES

20250345437

2025-11-13

GLUTEN-FREE MEDICATION AID COMPOSITION FOR COMPANION ANIMALS, AND METHOD FOR MANUFACTURING THE SAME

20250302794

2025-10-02

COMPOSITIONS, METHODS AND SYSTEMS FOR THE TREATMENT OF CUTANEOUS DISORDERS

20250289840

2025-09-18

RNA STABILIZING SUBSTANCES AND METHODS OF USE

20250288605

2025-09-18

OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY

20250195535

2025-06-19

PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM

20250177529

2025-06-05

ACOUSTIC ENRICHMENT OF ADOPTIVE CELL TRANSFERS

20250152501

2025-05-15

DISSOLVING MICRONEEDLE FOR TRANSDERMAL DELIVERY OF BIOPHARMACEUTICAL, AND MANUFACTURING METHOD THEREFOR

#10

20250090498

2025-03-20

TREATMENT OF PRIMARY CTLA-4 CHECKPOINT RELATED IMMUNODEFICIENCIES

#11

20250032463

2025-01-30

RAPAMYCIN-CONTAINING PHARMACEUTICAL COMPOSITION

#12

20240390513

2024-11-28

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES

#13

20240382543

2024-11-21

PERILESIONAL TREATMENT OF SKIN CONDITIONS

#14

20240307342

2024-09-19

Treatment of the adverse cardiovascular effects of cannabinoids

#15

20240247291

2024-07-25

COMB POLYELECTROLYTE STABILIZED COMPLEX COACERVATE EMULSIONS

#16

20240139204

2024-05-02

Pharmaceutical liquid compositions of meloxicam

#17

20240082191

2024-03-14

TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS

#18

20240082172

2024-03-14

METHOD FOR DEPOT CREATION DURING TRANSDERMAL DRUG DELIVERY

#19

20240082118

2024-03-14

TOPICAL COMPOSITIONS AND METHODS OF PREPARING THE SAME

#20

20230312615

2023-10-05

METAL-ORGANIC FRAMEWORKS FOR THE STORAGE AND DELIVERY OF HYDROGEN SULFIDE, METHODS OF MAKING AND USES OF SAME

#21

20230277691

2023-09-07

POLYMERS, SYSTEMS, AND METHODS FOR USING AND MONITORING POLYMERS FOR USE IN MEDICAL POLYMERS, IMPLANTS, AND PROCEDURES

#22

20230277636

2023-09-07

Composition comprising highly-concentrated Alpha1 proteinase inhibitor and method for obtaining thereof

#23

20230201138

2023-06-29

TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN

#24

20230135347

2023-05-04

HYDROGELS WITH BIODEGRADABLE CROSSLINKING

#25

20230085651

2023-03-23

ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS

#26

20230048901

2023-02-16

SOLID ORAL FORMULATION OF UTIDELONE

#27

20220389160

2022-12-08

EFFECTIVE INTRANASAL DELIVERY TO BRAIN

#28

20220378982

2022-12-01

MESENCHYMAL STEM CELLS-HYDROGEL-BIODEGRADABLE OR MESENCHYMAL STEM CELLS-HYDROGEL-NONDEGRADABLE SUPPORT COMPOSITION FOR ALLEVIATING OR IMPROVING EPIDERMOLYSIS BULLOSA

#29

20220257748

2022-08-18

HEPATITIS B VIRUS-SPECIFIC T CELL RESPONSES

#30

20220257679

2022-08-18

POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR

#31

20220249507

2022-08-11

PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM

#32

20220226475

2022-07-21

WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS AND METHODS OF DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES

#33

20220152091

2022-05-19

OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY

#34

20220000992

2022-01-06

Composition comprising highly-concentrated α1 proteinase inhibitor and method for obtaining thereof

#35

20210395203

2021-12-23

DUAL ACTING FKBP12 AND FKBP52 INHIBITORS

#36

20210393523

2021-12-23

AROMATIC RING SUBSTITUTED AMPHIPHILIC POLYMERS AS DRUG DELIVERY SYSTEMS

#37

20210369633

2021-12-02

Shear-thinning self-healing networks

#38

20210361826

2021-11-25

Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy

#39

20210330682

2021-10-28

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS INTO THE COLON

#40

20210283148

2021-09-16

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS INTO THE COLON

#41

20210230261

2021-07-29

BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES

#42

20210220283

2021-07-22

Method for manufacturing acetaminophen preparation

#43

20210177926

2021-06-17

Herbal medicine extracts and uses and methods of preparation thereof

#44

20210145777

2021-05-20

MODIFIED-RELEASE TIOPRONIN COMPOSITIONS, KITS AND METHODS FOR TREATING CYSTINURIA AND RELATED DISORDERS

#45

20200399219

2020-12-24

Dual acting FKBP12 and FKBP52 inhibitors

#46

20200362095

2020-11-19

Bottlebrush copolymers and uses thereof

#47

20200316012

2020-10-08

Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin

#48

20200222583

2020-07-16

Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy

#49

20200197326

2020-06-25

TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN

#50

20200078446

2020-03-12

Rapid-acting insulin compositions

#51

20200054756

2020-02-20

Hydrogels with biodegradable crosslinking

#52

20200054486

2020-02-20

BIODEGRADABLE INTRAVITREAL IMPLANTS

#53

20200038494

2020-02-06

Composition comprising highly-concentrated ALPHA1 proteinase inhibitor and method for obtaining thereof

#54

20200016080

2020-01-16

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS

#55

20190365644

2019-12-05

DRUG DELIVERY SYSTEM

#56

20190321289

2019-10-24

DRUG DELIVERY SYSTEM

#57

20190290779

2019-09-26

Composition for gene therapy or transfection, and preparation method and use thereof

#58

20190290762

2019-09-26

NANO-ARCHITECTURED COLLOIDOSOMES FOR CONTROLLED AND TRIGGERED RELEASE

#59

20190247451

2019-08-15

Microencapsulation of bacteriophages and related products

#60

20190224323

2019-07-25

Polytetrafluoroethylene co-polymer emulsions

#61

20190175520

2019-06-13

METHOD FOR DEPOT CREATION DURING TRANSDERMAL DRUG DELIVERY

#62

20190142754

2019-05-16

Method for manufacturing acetaminophen preparation

#63

20190142738

2019-05-16

TRANSDERMAL FORMULATIONS FOR DELIVERY OF CELECOXIB AND ITS USE IN THE TREATMENT OF CELECOXIB-RESPONSIVE DISEASES AND CONDITIONS

#64

20190141992

2019-05-16

ROD-SHAPED PLANT VIRAL NANOPARTICLES OR VIRUS-LIKE PARTICLES FOR AGRICULTURAL APPLICATIONS

#65

20190111140

2019-04-18

Chemical structures for localized delivery of therapeutic agents

#66

20190111109

2019-04-18

Polyelectrolyte complexes for delivery of agents to the CNS

#67

20190110982

2019-04-18

Drug depots for treatment of pain and inflammation

#68

20190060228

2019-02-28

Chewing gum composition for use in alleviation of xerostomia induced by radiotherapy treatment

#69

20190000979

2019-01-03

Polytetrafluoroethylene co-polymer emulsions

#70

20180312630

2018-11-01

Biodegradable trehalose glycopolymers

#71

20180289736

2018-10-11

Oxygen reactive polymers for treatment of traumatic brain injury

#72

20180250239

2018-09-06

Drug delivery system and methods of use

#73

20180236135

2018-08-23

Methods and compositions relating to biocompatible implants

#74

20180228917

2018-08-16

Shielded Targeting Agents, Methods, and In Vivo Diagnostic System

#75

20180161437

2018-06-14

Foamed Medical devices with Additives

#76

20180153964

2018-06-07

Pharmaceutical composition for treating sarcopenia including glucagon-like peptide-1 receptor agonist

#77

20180140619

2018-05-24

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS INTO THE COLON

#78

20180117217

2018-05-03

MESENCHYMAL STEM CELLS-HYDROGEL-BIODEGRADABLE OR MESENCHYMAL STEM CELLS-HYDROGEL-NONDEGRADABLE SUPPORT COMPOSITION FOR ALLEVIATING OR IMPROVING EPIDERMOLYSIS BULLOSA

#79

20180112034

2018-04-26

Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization

#80

20180094099

2018-04-05

Bottlebrush copolymers and uses thereof

#81

20180044381

2018-02-15

Polysaccharide derivative having membrane-permeable peptide chain

#82

20170360698

2017-12-21

Multi-Component Bolus

#83

20170333360

2017-11-23

Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications

#84

20170333350

2017-11-23

Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof

#85

20170319506

2017-11-09

Shear-thinning self-healing networks

#86

20170290780

2017-10-12

Transdermal composition containing donepezil as active ingredient

#87

20170216444

2017-08-03

PREPARATION FOR FORMING EMBOLI AND MICROCATHETER

#88

20170189553

2017-07-06

POLYMERS, SYSTEMS, AND METHODS FOR USING AND MONITORING POLYMERS FOR USE IN MEDICAL POLYMERS, IMPLANTS, AND PROCEDURES

#89

20170182207

2017-06-29

WOUND-HEALING-ENHANCING DEVICES

#90

20170173061

2017-06-22

Exercise performance enhancers

#91

20170172929

2017-06-22

PHARMACEUTICAL COMPOSITION CONTAINING PREGABALIN WITH IMPROVED STABILITY AND METHOD FOR PREPARING SAME

#92

20170157144

2017-06-08

Preparation method for antithyroid ointment for external application

#93

20170143802

2017-05-25

Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate

#94

20170112761

2017-04-27

Functional polymer gel containing organic nanotubes and method for producing same

#95

20170107198

2017-04-20

MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF

#96

20170100376

2017-04-13

Solid dosage forms of bendamustine

#97

20170042963

2017-02-16

Anticancer peptide for inhibiting proliferation of cancer stem cells and use thereof

#98

20170028101

2017-02-02

Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy

#99

20170014337

2017-01-19

DRUG DEPOTS FOR TREATMENT OF PAIN AND INFLAMMATION IN SINUS AND NASAL CAVATIES

#100

20160375138

2016-12-29

Consumer goods product comprising functionalised lignin oligomer

#101

20160374922

2016-12-29

Consumer goods product comprising functionalised lignin oligomer

#102

20160250129

2016-09-01

Solution solubilization composition of insoluble material and method for solubilizing insoluble material using same

#103

20160184436

2016-06-30

TRANSDERMAL DELIVERY PATCH

#104

20160129131

2016-05-12

Shielded targeting agents, methods, and in vivo diagnostic system

#105

20160074518

2016-03-17

Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid

#106

20160074335

2016-03-17

FIBER/GRANULE COMPLEX FOR TREATMENT OF THE GI TRACT

#107

20160067344

2016-03-10

Compounds and medical devices activated with solvophobic linkers

#108

20160022486

2016-01-28

Drug delivery devices and methods

#109

20160017326

2016-01-21

MICRORNAS AS FUNCTIONAL MEDIATORS AND BIOMARKERS OF BONE METASTASIS

#110

20150368359

2015-12-24

COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS

#111

20150250887

2015-09-10

METHOD OF PREPARING RESIN TINCTURES

#112

20150231255

2015-08-20

ABSORPTION PROMOTING AGENT AND PATCH COMPRISING SAME

#113

20150190553

2015-07-09

Embolic devices

#114

20150165042

2015-06-18

Biodegradable compositions suitable for controlled release

#115

20150148899

2015-05-28

Sodium channel blocker delivery system with scleral lens

#116

20150148431

2015-05-28

Transdermal delivery patch

#117

20150147395

2015-05-28

Compounds and medical devices activated with solvophobic linkers

#118

20150017240

2015-01-15

Pharmaceutical compositions comprising a pH-dependent component and pH-raising agent

#119

20150010490

2015-01-08

Anti-adhesion polymer composition capable of supporting growth factor

#120

20140348815

2014-11-27

Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications

#121

20140330244

2014-11-06

Implantable Device for Manipulating Immune Cells

#122

20140309277

2014-10-16

Lipids, lipid compositions, and methods of using them

#123

20140248313

2014-09-04

Combination adjuvant formulation

#124

20140227330

2014-08-14

CAPSULE WHOSE ENVELOPE IS SEPARATELY IMPERCEPTIBLE DURING THE TOPICAL USE THEREOF

#125

20140219923

2014-08-07

Biodegradable compositions suitable for controlled release

#126

20140171885

2014-06-19

Drug delivery devices and methods

#127

20140161720

2014-06-12

TREATMENT OF ANGIOGENIC- OR VASCULAR-ASSOCIATED DISEASES

#128

20140155495

2014-06-05

TRANSDERMAL DELIVERY PATCH

#129

20140148486

2014-05-29

Sodium channel blocker delivery system with scleral lens

#130

20140135407

2014-05-15

Biodegradable nanocomposites with enhanced mechanical properties for soft tissue engineering

#131

20140080921

2014-03-20

Biodisintegrable medical devices

#132

20140072518

2014-03-13

Polytetrafluoroethylene co-polymer emulsions

#133

20140072514

2014-03-13

Polytetrafluoroethylene co-polymer emulsions

#134

20140050690

2014-02-20

Nanoparticle containing prostaglandin Iderivative

#135

20140044787

2014-02-13

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS

#136

20140004190

2014-01-02

Solid Dosage Forms of Bendamustine

#137

20130261179

2013-10-03

Stabilised prostaglandin composition

#138

20130225857

2013-08-29

Crosslinked polymers with the crosslinker as therapeutic for sustained release

#139

20130190401

2013-07-25

Veterinary dermatologic composition

#140

20130189341

2013-07-25

GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES

#141

20130178415

2013-07-11

Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid

#142

20130171208

2013-07-04

COMPOSITIONS OF NANOPARTICLES AND METHODS OF MAKING THE SAME

#143

20130116212

2013-05-09

OIL-BASED GEL-LIKE COMPOSITION

#144

20130108707

2013-05-02

In situ film-forming bioactive solutions of absorbable multiblock copolymers

#145

20130096194

2013-04-18

ANTIMICROBIAL ARTICLES

#146

20130089585

2013-04-11

FILLER COMPRISING BEADS

#147

20120276221

2012-11-01

BIODISINTEGRABLE MEDICAL DEVICES

#148

20120217182

2012-08-30

TABLET MANUFACTURE

#149

20120201891

2012-08-09

Transdermal delivery patch

#150

20120197114

2012-08-02

Nanocarriers for imaging and therapy applications

#151

20120197028

2012-08-02

Crosslinked polymers with the crosslinker as therapeutic for sustained release

#152

20120184615

2012-07-19

Stabilised prostaglandin composition

#153

20120035321

2012-02-09

Compounds and medical devices activated with solvophobic linkers

#154

20120015997

2012-01-19

PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE

#155

20120003309

2012-01-05

Solid Dosage Forms Of Bendamustine

#156

20110250256

2011-10-13

Dissolvable Nano Web Porous Film and Method of Preparing the Same

#157

20110244046

2011-10-06

Charge reversible polymers

#158

20110238075

2011-09-29

Drug delivery devices and methods

#159

20110217255

2011-09-08

Block copolymers and their use

#160

20110213358

2011-09-01

Tissue-treatment methods

#161

20110201680

2011-08-18

Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof

#162

20110200582

2011-08-18

LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM

#163

20110091566

2011-04-21

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS

#164

20110091560

2011-04-21

COMPOSITIONS OF NANOPARTICLES AND METHODS OF MAKING THE SAME

#165

20110071631

2011-03-24

Sodium channel blocker delivery system with scleral lens

#166

20110071630

2011-03-24

SODIUM CHANNEL BLOCKER DELIVERY SYSTEM WITH SCLERAL LENS

#167

20100278899

2010-11-04

EDIBLE FILM

#168

20100273721

2010-10-28

Compositions and methods for treating ophthalmic disorders

#169

20100258977

2010-10-14

Methods for Forming Microporous and Antimicrobial Articles

#170

20100239632

2010-09-23

DRUG DEPOTS FOR TREATMENT OF PAIN AND INFLAMMATION IN SINUS AND NASAL CAVITIES OR CARDIAC TISSUE

#171

20100239611

2010-09-23

Combination adjuvant formulation

#172

20100233269

2010-09-16

MINERALIZED POLYMER PARTICLES AND THE METHOD FOR THEIR PRODUCTION

#173

20100080768

2010-04-01

Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin

#174

20100036002

2010-02-11

PHARMACEUTICAL COMPOSITION COMPRISING POROUS DRY MATRIX

#175

20100021502

2010-01-28

Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT

#176